AMAM

Ambrx Biopharma (AMAM)

Ambrx Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AMAM

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/10/13	05 : 20	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/13	05 : 15	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/13	05 : 10	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/13	05 : 05	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/12	19 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/11	05 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/11	00 : 35	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/07	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMAM	Ambrx Biopharma Inc
2023/09/26	06 : 24	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NYSE:AMAM	Ambrx Biopharma Inc
2023/07/08	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/29	05 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/29	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/09	05 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/26	05 : 08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/19	05 : 28	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/19	05 : 24	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/17	05 : 07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/12	05 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/06	05 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/06	05 : 06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/05	05 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	07 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	05 : 22	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	05 : 09	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/28	05 : 11	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:AMAM	Ambrx Biopharma Inc